TEM Tempus AI, Inc.
Company Analysis
Latest News
🔴 Tempus AI is trading 4.07% down today amid broader technology and AI-stock weakness
Tempus AI is trading 4.07% down now at $49.54, moving with broader weakness in technology and AI stocks. • The Nasdaq Composite is down 1.22%, and the S&P 500...
🔴 Tempus AI is trading 4.16% down today; specific catalyst remains unclear
Tempus AI is trading at $52.03 (-4.16%), with the specific catalyst unclear. - No clear company-specific announcement or analyst action surfaced for August...
🟢 Tempus AI is trading 4.72% up today as August 7’s software rally extends
Tempus AI is trading $54.51 (+4.72%) as the advance appears to extend August 7’s 12.86% rally, when strong Atlassian and Doximity results lifted software...
🟢 Tempus AI is trading 11.22% up today after Atlassian and Doximity results lifted software stocks
Tempus AI is trading at $51.29, up 11.22%, as software stocks rise after strong Atlassian and Doximity results lifted the sector. - A weaker-than-expected...
🟢 Tempus AI is trading 9.2% up today following a broader software-sector rally
Tempus AI is trading 9.2% up at $50.26, following a broader software-sector rally. - The IGV software ETF is up 3.48% during regular trading as Atlassian and...
Tempus AI Validates PRISM2 Model, Outperforming Rivals in Nature Medicine Study
Tempus AI announced a new study in Nature Medicine validating its PRISM2 AI-powered pathology model. The model, developed in collaboration with Microsoft,...
Tempus AI's second quarter revenue rose 22% as it swung to a surprise profit and raised its 2026 outlook.
Tempus AI reported second quarter revenue of $382.5 million, a 22% increase year-over-year, and a significant beat on profitability with a GAAP EPS of $0.03...
🟢 Tempus AI is trading 4.1% up today ahead of Q2 earnings and a Personalis acquisition update
Tempus AI is trading at $43.24 (+4.1%) as investors position ahead of its Q2 2026 earnings report and an integration update on the $1.5 billion all-stock...
Tempus AI, Inc. Q2 2026 Earnings Preview: What Analysts Expect on July 30, 2026
Tempus AI is projected to report Q2 2026 revenue of $381.6 million and an EPS loss of $0.41, with its current share price of $43.96 trading significantly below...
🔴 Tempus AI is trading 4.2% down today on AI spending and China competition concerns
Tempus AI is trading 4.2% down today at $41.13 as part of a broader pullback in artificial intelligence and technology stocks. • The move comes as...
🔴 Tempus AI is trading 4.4% down today as risk-off sentiment hits AI and tech stocks
Tempus AI is trading 4.4% down at $43.97 today, extending a sharp multi-day slide as broader market sentiment turns cautious on the technology sector. • The...
Tempus AI Announces Agreement to Acquire Personalis, Inc. for $16.25 Per Share
Tempus AI, Inc. (TEM) has entered into a definitive merger agreement to acquire Personalis, Inc. in a stock and potential cash transaction. The deal values...
Tempus AI to Acquire Personalis for $1.5 Billion to Expand Cancer Monitoring
Tempus AI (TEM) announced it has entered into a definitive agreement to acquire Personalis, Inc. (PSNL) for a total enterprise value of $1.5 billion. The...
Tempus AI to acquire Personalis for $1.5B, expanding cancer monitoring tech
Tempus AI (NASDAQ: TEM) signed a definitive agreement to acquire Personalis, Inc. (NASDAQ: PSNL) for approximately $1.5 billion. The deal values Personalis at...
🔴 Tempus AI is trading 6.1% down today on muted 2026 guidance and sector rotation
Tempus AI is trading at $49.26 (6.1% down) amid continued weakness in high-growth AI and healthcare technology stocks. • The decline extends a multi-session...
🔴 Tempus AI is trading 5.4% down today as AI rotation continues
Tempus AI is trading 5.4% down at $49.65 amid ongoing weakness in high-growth AI and healthcare technology names. • The stock has been sliding for several...
🔴 Tempus AI is trading 4.1% down today as investors rotate out of high-growth AI names
Tempus AI is trading at $51.41 (4.1% down) as investors continue to rotate out of high-growth AI and healthcare technology names. • The stock is being...
🔴 Tempus AI is trading 4.4% down today amid broader tech and AI sector pressure
Tempus AI is trading 4.4% down at $54.71 today amid broader pressure on technology and AI-related stocks. • The Nasdaq Composite is trading lower, weighing on...
Tempus AI Showcases Successful Prostate Cancer AI Deployment in UK's NHS
Tempus AI highlighted the publication of the Articulate Pro study. The study demonstrated the safe, real-world deployment of its Paige Prostate AI Suite within...
🟢 Tempus AI is trading 4.2% up today on bullish analyst coverage and cooling inflation data
Tempus AI is trading 4.2% up at $58.27 as investors digest recent bullish analyst coverage and a favorable macroeconomic environment for growth stocks. - The...